Caroline Fecher

Caroline Fecher

Auto-generated profile, based on publicly available information

Caroline Fecher

Institute of Neuronal Cell Biology, Technical University of Munich, Munich, Germany

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2019 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
CFCaroline Fecher
Caroline Fecher
LTLaura Trovò
Laura Trovò
SMStephan Alexander Mueller
Stephan Alexander Mueller
NSNicolas Snaidero
Nicolas Snaidero
JWJennifer Wettmarshausen
Jennifer Wettmarshausen
TMThomas Misgeld
Thomas Misgeld

1 July 2011 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
CWChristian Weber
Christian Weber
SMSvenja Meiler
Svenja Meiler
YDYvonne Döring
Yvonne Döring
MKMiriam Koch
Miriam Koch
MDMaik Drechsler
Maik Drechsler
AZAlma Zernecke
Alma Zernecke
Immune mechanisms are known to control the pathogenesis of atherosclerosis. However, the exact role of DCs, which are essential for priming of immune responses, remains elusive. We have shown here that the DC-derived chemokine CCL17 is present in advanced human and mouse atherosclerosis and that CCL17+ DCs accumulate in atherosclerotic lesions. In atherosclerosis-prone mice, Ccl17 deficiency entailed a reduction of atherosclerosis, which was dependent on Tregs. Expression of CCL17 by DCs limited the expansion of Tregs by restricting their maintenance and precipitated atherosclerosis in a mechanism conferred by T cells. Conversely, a blocking antibody specific for CCL17 expanded Tregs and reduced atheroprogression. Our data identify DC-derived CCL17 as a central regulator of Treg homeostasis, implicate DCs and their effector functions in atherogenesis, and suggest that CCL17 might be a target for vascular therapy.

23 April 2020 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
TBTobias Baumann
Tobias Baumann
ADAndreas Dunkel
Andreas Dunkel
CSChristian Schmid
Christian Schmid
SSSabine Schmitt
Sabine Schmitt
MHMichael Hiltensperger
Michael Hiltensperger
BHBastian Höchst
Bastian Höchst

15 August 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
NLNoah M. Lancaster
Noah M. Lancaster
PSPavel Sinitcyn
Pavel Sinitcyn
PFPatrick Forny
Patrick Forny
TPTrenton M. Peters-Clarke
Trenton M. Peters-Clarke
CFCaroline Fecher
Caroline Fecher
JCJoshua J. Coon
Joshua J. Coon
Owing to its roles in cellular signal transduction, protein phosphorylation plays critical roles in myriad cell processes. That said, detecting and quantifying protein phosphorylation has remained a challenge. We describe the use of a novel mass spectrometer (Orbitrap Astral) coupled with data-independent acquisition (DIA) to achieve rapid and deep analysis of human and mouse phosphoproteomes. With this method, we map approximately 30,000 unique human phosphorylation sites within a half-hour of data collection. The technology is benchmarked to other state-of-the-art MS platforms using both synthetic peptide standards and with EGF-stimulated HeLa cells. We apply this approach to generate a phosphoproteome multi-tissue atlas of the mouse. Altogether, we detect 81,120 unique phosphorylation sites within 12 hours of measurement. With this unique dataset, we examine the sequence, structural, and kinase specificity context of protein phosphorylation. Finally, we highlight the discovery potential of this resource with multiple examples of phosphorylation events relevant to mitochondrial and brain biology.

10 July 2023 in Nature Metabolism
Verified
Journal Article
Open access
PDF file
YTYi-Heng Tai
Yi-Heng Tai
DEDaniel Engels
Daniel Engels
GLGiuseppe Locatelli
Giuseppe Locatelli
IEIoanna Emmanouilidis
Ioanna Emmanouilidis
CFCaroline Fecher
Caroline Fecher
TMThomas Misgeld
Thomas Misgeld
Inflammation in the central nervous system can impair the function of neuronal mitochondria and contributes to axon degeneration in the common neuroinflammatory disease multiple sclerosis (MS). Here we combine cell-type-specific mitochondrial proteomics with in vivo biosensor imaging to dissect how inflammation alters the molecular composition and functional capacity of neuronal mitochondria. We show that neuroinflammatory lesions in the mouse spinal cord cause widespread and persisting axonal ATP deficiency, which precedes mitochondrial oxidation and calcium overload. This axonal energy deficiency is associated with impaired electron transport chain function, but also an upstream imbalance of tricarboxylic acid (TCA) cycle enzymes, with several, including key rate-limiting, enzymes being depleted in neuronal mitochondria in experimental models and in MS lesions. Notably, viral overexpression of individual TCA enzymes can ameliorate the axonal energy deficits in neuroinflammatory lesions, suggesting that TCA cycle dysfunction in MS may be amendable to therapy.

7 May 2013 in Journal of Visualized Experiments
Verified
Journal Article
Closed access
PDF file
SSSamira Samtleben
Samira Samtleben
JJJuliane Jaepel
Juliane Jaepel
CFCaroline Fecher
Caroline Fecher
TAThomas Andreska
Thomas Andreska
MRMarkus Rehberg
Markus Rehberg
RBRobert Blum
Robert Blum
Targeted-esterase induced dye loading (TED) supports the analysis of intracellular calcium store dynamics by fluorescence imaging. The...